ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Aclaris Therapeutics, INC.

Official 2024 U.S. DOL Form 5500 summary for Aclaris Therapeutics, INC. (Aclaris Therapeutics INC 401(k) Plan · EIN 46-0571712 · PN 001): $14.07M net assets, 67 active participants, and $26.79 per $10,000 (26.79 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAclaris Therapeutics, INC.
Filing IdentifierAclaris Therapeutics INC 401(k) Plan · EIN 46-0571712 · PN 001
Plan Category & State401(k) Defined Contribution (PA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$14.07M
Active Participants67
Direct Admin Fee Rate$26.79 per $10,000 (26.79 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderT. Rowe Price
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI